Avecia Group plc
Avecia has become dependent on pharmaceuticals, and it doesn't want to kick the habit. After much pruning, the specialty and fine chemicals maker has two main segments: oligomedicines and biologics. The biologics unit, based in the UK, develops microbial and human therapeutic proteins. The other business segment provides oligonucleotide products for all stages of production: pre-clinical, clinical, and post launch. This oligomedicines unit is headquartered in Massachusetts. In the latter half of the decade the company began a reorganization that involved selling off its chemicals unit that made products for laser printers and copiers and intermediates for pharmaceuticals and agricultural chemicals.
Contact Details
Office Address
Avecia Group plc
Hexagon Tower,
Blackley, Manchester, UK M98ZS
Phone: +44-161-721-1013
Fax: +44-161-721-5202
Executives
CEO and Director
Jeremy P. Scudamore
COO and Director
David C. Greensmith
CFO and Director
Derrick A. Nicholson